Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Cancer Recurrent”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT07569926
What this trial is testing

Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence

Who this might be right for
Prostate Cancer
Blue Earth Diagnostics 142
Early research (Phase 1)Looking for participantsNCT05997615
What this trial is testing

Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

Who this might be right for
Hormone-refractory Prostate Cancer
Astellas Pharma Global Development, Inc. 437
Large-scale testing (Phase 3)Looking for participantsNCT05352178
What this trial is testing

Metastasis-directed Therapy for Oligorecurrent Prostate Cancer

Who this might be right for
Prostate CancerProstate Cancer RecurrentProstate Cancer Metastatic+4 more
Universitaire Ziekenhuizen KU Leuven 873
Testing effectiveness (Phase 2)Study completedNCT00083005
What this trial is testing

Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate

Who this might be right for
Prostate Cancer
National Institutes of Health Clinical Center (CC) 60
Testing effectiveness (Phase 2)Study completedNCT00045227
What this trial is testing

Vaccine Therapy With or Without Docetaxel in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT02807805
What this trial is testing

Abiraterone Acetate, Niclosamide, and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer

Who this might be right for
Metastatic Prostate CarcinomaRecurrent Prostate CarcinomaStage IV Prostate Cancer
Mamta Parikh 37
Post-approval studies (Phase 4)Study completedNCT06604442
What this trial is testing

Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy

Who this might be right for
Prostate Cancer
Blue Earth Diagnostics 62
Not applicableLooking for participantsNCT06862856
What this trial is testing

Flotufolastat F 18 PET in Men With Very Low PSA Recurrence

Who this might be right for
Prostate Cancer (Adenocarcinoma)Prostate Specific Antigen
Massachusetts General Hospital 50
Large-scale testing (Phase 3)Ended earlyNCT04409288
What this trial is testing

Patient Preference of Apalutamide Versus Enzalutamide in Patients With Recurrent or Metastatic Hormone-Sensitive Prostate Cancer

Who this might be right for
Prostate Cancer
Chinese University of Hong Kong 74
Testing effectiveness (Phase 2)Study completedNCT04011410
What this trial is testing

Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer

Who this might be right for
Prostate Cancer Recurrent
Patrick Hensley 20
Large-scale testing (Phase 3)Study completedNCT00104715
What this trial is testing

Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
UNICANCER 385
Testing effectiveness (Phase 2)Active Not RecruitingNCT03600350
What this trial is testing

PTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 19
Testing effectiveness (Phase 2)Study completedNCT00005810
What this trial is testing

Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
Alliance for Clinical Trials in Oncology 40
Not applicableEnded earlyNCT00288106
What this trial is testing

S0437 Long-Term Follow-Up of Patients Who Were Diagnosed With Prostate Cancer on PCPT

Who this might be right for
Prostate Cancer
SWOG Cancer Research Network 961
Early research (Phase 1)Ended earlyNCT01174199
What this trial is testing

Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate CancerAdenocarcinoma of the ProstateHormone-resistant Prostate Cancer+2 more
Roswell Park Cancer Institute 13
Testing effectiveness (Phase 2)Study completedNCT02499835
What this trial is testing

Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Malignant Neoplasm in the BoneMetastatic Malignant Neoplasm in the Soft Tissues+4 more
University of Wisconsin, Madison 66
Testing effectiveness (Phase 2)UnknownNCT00003717
What this trial is testing

Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
St. Barnabas Medical Center 17
Large-scale testing (Phase 3)Study completedNCT02260817
What this trial is testing

Expanded Access to Diagnostic Imaging for Staging of Recurrent Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Global Isotopes, LLC d/b/a Zevacor Molecular 109
Early research (Phase 1)Looking for participantsNCT07090148
What this trial is testing

Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC

Who this might be right for
Prostate Cancer PatientsNon-castrate Prostate CancerRecurrent Prostate Cancer+1 more
University of Wisconsin, Madison 14
Testing effectiveness (Phase 2)Study completedNCT01304485
What this trial is testing

PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate Carcinoma

Who this might be right for
Prostate Cancer
Phoenix Molecular Imaging 2,000
Next Page